David A. Siegel Bristol Myers Squibb CO Transaction History

Two Sigma Advisers, LP

$47 Billion
Q3 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Two Sigma Advisers, LP holds 4,721,300 shares of BMY stock, worth $221 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

4,721,300

Previous 1,117,500 322.49%

Holding current value

$221 Million

Previous $51.7 Million 311.63%

% of portfolio

0.45%

Previous 0.11%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$43.31 - $48.98 $156 Million - $177 Million	3,603,800 Added 322.49%	4,721,300 $213 Million
Q2 2025 Aug 14, 2025	BUY	$44.12 - $59.6 $16.7 Million - $22.6 Million	379,000 Added 51.32%	1,117,500 $51.7 Million
Q1 2025 May 15, 2025	SELL	$53.9 - $63.11 $60.3 Million - $70.6 Million	-1,119,400 Reduced 60.25%	738,500 $45 Million
Q4 2024 Feb 14, 2025	SELL	$51.92 - $59.94 $399 Million - $461 Million	-7,692,600 Reduced 80.55%	1,857,900 $105 Million
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $71.5 Million - $93.3 Million	-1,803,600 Reduced 15.89%	9,550,500 $494 Million

Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $97.1 Million - $128 Million	2,413,600 Added 27.0%	11,354,100 $472 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $1.76 Million - $2 Million	36,700 Added 0.41%	8,940,500 $485 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $111 Million - $132 Million	2,283,700 Added 34.5%	8,903,800 $457 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $275 Million - $307 Million	4,746,800 Added 253.39%	6,620,100 $384 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $94.1 Million - $104 Million	1,477,000 Added 372.7%	1,873,300 $120 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $624,179 - $707,960	-9,499 Reduced 2.34%	396,300 $27.5 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $181 Million - $215 Million	-2,648,200 Reduced 86.71%	405,799 $29.2 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $215,852 - $128 Million	-1,660,400 Reduced 35.22%	3,053,999 $217 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $25.7 Million - $28.3 Million	354,200 Added 8.12%	4,714,399 $363 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $139 Million - $166 Million	-2,256,400 Reduced 34.1%	4,360,199 $318 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $713,279 - $831,516	13,300 Added 0.2%	6,616,599 $413 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $342 Million - $401 Million	5,787,600 Added 709.53%	6,603,299 $391 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $49.3 Million - $53.7 Million	796,399 Added 4126.42%	815,699 $54.5 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $75.5 Million - $84.9 Million	-1,272,646 Reduced 98.51%	19,300 $1.22 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $227 Million - $258 Million	-3,936,100 Reduced 75.29%	1,291,946 $80.1 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $83.9 Million - $92.9 Million	1,460,315 Added 38.76%	5,228,046 $315 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $142 Million - $166 Million	2,587,299 Added 219.18%	3,767,731 $222 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $247 Million - $359 Million	-5,321,599 Reduced 81.85%	1,180,432 $65.8 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $107 Million - $139 Million	-2,165,301 Reduced 24.98%	6,502,031 $417 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $3.52 Million - $4.17 Million	82,200 Added 0.96%	8,667,332 $440 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $23.2 Million - $25.7 Million	521,000 Added 6.46%	8,585,132 $389 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $238 Million - $284 Million	5,280,400 Added 189.69%	8,064,132 $385 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $66.5 Million - $86.2 Million	1,363,900 Added 96.06%	2,783,732 $145 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $6.44 Million - $7.26 Million	-116,600 Reduced 7.59%	1,419,832 $88.1 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $14.2 Million - $17.7 Million	-281,700 Reduced 15.49%	1,536,432 $85 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $67.5 Million - $77.7 Million	-1,126,826 Reduced 38.26%	1,818,132 $115 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $73.2 Million - $79.9 Million	-1,221,956 Reduced 29.33%	2,944,958 $180 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $230 Million - $266 Million	4,166,914	4,166,914 $266 Million

Others Institutions Holding BMY

# of Institutions

2,692

Shares Held

1.58B

Call Options Held

28M

Put Options Held

28.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.5B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account